Home > Qtrly Results > ALEMBIC PHARMACEUTICALS

ALEMBIC PHARMACEUTICALS
Quarterly Results Analysis [Sep2024]

ALEMBIC PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ALEMBIC PHARMACEUTICALS
Please provide your vote to see the results

ALEMBIC PHARMACEUTICALS Quarterly Results

Consolidated Sep2024
Audited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
Audited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Revenues ₹1,648 Cr ₹1,562 Cr ₹1,517 Cr ₹1,631 Cr ₹1,595 Cr ₹1,486 Cr ₹1,406 Cr ₹1,509 Cr
Expenses ₹1,409 Cr ₹1,325 Cr ₹1,257 Cr ₹1,364 Cr ₹1,387 Cr ₹1,287 Cr ₹1,194 Cr ₹1,260 Cr
Operating Income ₹239 Cr ₹237 Cr ₹260 Cr ₹266 Cr ₹208 Cr ₹199 Cr ₹212 Cr ₹249 Cr
Other Income ₹17 Cr ₹2 Cr ₹4 Cr ₹3 Cr ₹10 Cr ₹12 Cr ₹1 Cr ₹0 Cr
Interest ₹19 Cr ₹13 Cr ₹11 Cr ₹15 Cr ₹16 Cr ₹14 Cr ₹14 Cr ₹15 Cr
Depreciation ₹71 Cr ₹69 Cr ₹69 Cr ₹69 Cr ₹68 Cr ₹66 Cr ₹74 Cr ₹67 Cr
Profit Before Tax ₹180 Cr ₹157 Cr ₹183 Cr ₹185 Cr ₹135 Cr ₹130 Cr ₹125 Cr ₹168 Cr
Profit After Tax ₹152 Cr ₹134 Cr ₹179 Cr ₹181 Cr ₹137 Cr ₹121 Cr ₹161 Cr ₹136 Cr
EPS ₹7.81 ₹6.85 ₹9.07 ₹9.18 ₹6.95 ₹6.14 ₹7.76 ₹6.20
Industry Peers & Returns1W1M1Y
ALEMBIC PHARMACEUTICALS -0.2% -2.2% 32.8%
SUN PHARMACEUTICAL INDUSTRIES -2% 2.1% 42.6%
CIPLA -2.6% -0.6% 17.9%
DR REDDYS LABORATORIES -2.7% 8.9% 14.2%
ZYDUS LIFESCIENCES -1% -1.7% 36.9%
DIVIS LABORATORIES -3.5% -3.4% 49.9%
MANKIND PHARMA 0.2% 10.2% 39.7%
TORRENT PHARMACEUTICALS -0.2% -0.3% 46.5%
LUPIN 0.3% 10.9% 69.7%

ALEMBIC PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

5.52 %

Y-o-Y

3.33 %

Quarters Revenues % Change
Sep2024 ₹1,648 Cr
5.52
Jun2024 ₹1,562 Cr
2.95
Mar2024 ₹1,517 Cr
-6.97
Dec2023 ₹1,631 Cr
2.23
Sep2023 ₹1,595 Cr
7.32
Jun2023 ₹1,486 Cr
5.67
Mar2023 ₹1,406 Cr
-6.80
Dec2022 ₹1,509 Cr -

ALEMBIC PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

1.03 %

Y-o-Y

14.90 %

Quarters Operating Profit % Change
Sep2024 ₹239 Cr
1.03
Jun2024 ₹237 Cr
-8.93
Mar2024 ₹260 Cr
-2.37
Dec2023 ₹266 Cr
27.91
Sep2023 ₹208 Cr
4.80
Jun2023 ₹199 Cr
-6.37
Mar2023 ₹212 Cr
-14.69
Dec2022 ₹249 Cr -
Operating Margins
Q-o-Q

-4.22 %

Y-o-Y

11.18 %

Quarters Operating Margin% % Change
Sep2024 14.52%
-4.22
Jun2024 15.16%
-11.55
Mar2024 17.14%
4.90
Dec2023 16.34%
25.11
Sep2023 13.06%
-2.32
Jun2023 13.37%
-11.40
Mar2023 15.09%
-8.43
Dec2022 16.48% -

ALEMBIC PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

13.46 %

Y-o-Y

11.10 %

Quarters Profit After Tax % Change
Sep2024 ₹152 Cr
13.46
Jun2024 ₹134 Cr
-24.85
Mar2024 ₹179 Cr
-1.05
Dec2023 ₹181 Cr
31.68
Sep2023 ₹137 Cr
13.63
Jun2023 ₹121 Cr
-25.10
Mar2023 ₹161 Cr
18.84
Dec2022 ₹136 Cr -
PAT Margins
Q-o-Q

7.57 %

Y-o-Y

7.57 %

Quarters PAT Margin(%) % Change
Sep2024 9.24 %
7.57
Jun2024 8.59 %
-27.02
Mar2024 11.77 %
6.32
Dec2023 11.07 %
28.87
Sep2023 8.59 %
5.79
Jun2023 8.12 %
-29.08
Mar2023 11.45 %
27.51
Dec2022 8.98 % -

ALEMBIC PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

14.01 %

Y-o-Y

12.37 %

Quarters EPS % Change
Sep2024 ₹7.81
14.01
Jun2024 ₹6.85
-24.48
Mar2024 ₹9.07
-1.20
Dec2023 ₹9.18
32.09
Sep2023 ₹6.95
13.19
Jun2023 ₹6.14
-20.88
Mar2023 ₹7.76
25.16
Dec2022 ₹6.2 -

You may also like the below Video Courses